Multisystem inflammatory syndrome in children after BNT162b2 messenger RNA SARS-CoV-2 vaccination

Pediatr Int. 2023 Jan;65(1):e15441. doi: 10.1111/ped.15441.

Authors

Kana Sakaida¹, Satoru Iwashima¹, Junichiro Katsuki¹, Keisuke Sato², Isao Miyairi³

Affiliations

¹ Department of Pediatrics, Chutoen General Medical Center, Kakegawa, Japan.
² Department of Cardiology, Shizuoka Children's Hospital, Shizuoka, Japan.
³ Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, Japan.

No abstract available

Keywords: BNT162b2 mRNA SARS-CoV-2 vaccine; COVID-19; multisystem inflammatory syndrome.

MeSH terms

Antibodies, Viral
BNT162 Vaccine*
COVID-19 Vaccines
COVID-19*
Child
Humans
SARS-CoV-2
Vaccination

Substances

BNT162 Vaccine
COVID-19 Vaccines
Antibodies, Viral

Supplementary concepts

pediatric multisystem inflammatory disease, COVID-19 related